Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-21-010568
Filing Date
2021-02-19
Accepted
2021-02-19 16:01:23
Documents
2
Period of Report
2021-02-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2995
2 POWER OF ATTORNEY ea135975-ex24.htm EX-24 6377
  Complete submission text file 0001213900-21-010568.txt   10820
Mailing Address C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER STREET WALTHAM MA 02451
Business Address
Piekos Brian (Reporting) CIK: 0001815308 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39438 | Film No.: 21655534

Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Issuer) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations